Tag | Content |
---|
EnhancerAtlas ID | HS020-44714 |
Organism | Homo sapiens |
Tissue/cell | CD34+ |
Coordinate | chr9:37199980-37202050 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
ALX3 | MA0634.1 | chr9:37200357-37200367 | TTTAATTAGA | - | 6.02 | IRF1 | MA0050.2 | chr9:37200489-37200510 | ATGTGCTTTCTTTTTCCATTT | + | 6.41 | Mafb | MA0117.2 | chr9:37201374-37201386 | TGTCAGCATATT | - | 6.11 | Mecom | MA0029.1 | chr9:37200806-37200820 | GCTTATCTTTTCTT | - | 6 |
|
| Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
SE_10781 | chr9:37195113-37202567 | CD19_Primary | SE_10849 | chr9:37182197-37203858 | CD20 | SE_62012 | chr9:37185183-37211288 | Toledo |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH09I037199 | chr9 | 37199913 | 37201922 |
|
Enhancer Sequence | GCGTGAGCCA CTGTGCCAGG ACTGTTTCTT TTTCTTACCG CGCTCTGCTC CCATTTTTGC 60 CTTCCCATTT GTGCGCCACC ATTATTAAAT GCTTTATATT CTCTCTTTTG ATTGGGTTAC 120 ACGTTCTTTT ATTCTTCCTA TTCTTAATCC TTTGTGTTTT CTCTGTTACT TTGTTTTTCT 180 AATTTCCTCT CTCTTTGTTA TCTTTTTCTG TTTTCTTCTC CATGTTCACT TCCTTTTTTT 240 ATTATCTTTC AACTCTCCTC CTTTTTTCAC TCTTCACTGT GTATCATTAA AAAATAAAAA 300 CAAACCCGAA AACAAAACAT AAGCTCTTGG CTGTATTCAG GCCTCATTTT GTGCTTAATT 360 TCCATGTTTC CTGTTGCTTT AATTAGAGCT GACACCAAGT TTTCCCCTTC ATTTATGACT 420 TTTCATTGTT TTCCTCATAT TCCTTACCCA TAACAAATCT TAAAAAGCTA TAATCCCAGC 480 TGTTCTCCAT CACCATCATG TCCAACTCCA TGTGCTTTCT TTTTCCATTT TTCTTCCAGT 540 GATTTTATGT ATGTGTGTTT ATTAAAGTCC TAAAATGGGG AAAGTATGGC TGATGTGCAA 600 CTGTTGAGTC CTGCAATACT GGCTTTTCTG CCTCCTAGAA GCCTTGGTGG TGAGGGTAGA 660 AGCGGGAGCC AATTCATAAA AAGAGAGTGA AGAGTCAAAT AAGAAATTTG AGGGTGTTTA 720 TAGCTGTCTG TAAATTATGC TTTGTGGAAA ATAGAGTTGG AAGTGTAATT GAGGAACAGG 780 AGTAGACCAG AAATATGAAC CATTGAAAGG CTCTCTGCTT AAAGATGCTT ATCTTTTCTT 840 CCCTTCCCCT GTGACTCATA CCTACTGTTC ATTAGAAATG CATGTGTTTT AACTGGTCTT 900 TTTTAAAATG AAAATGTTCT GTAATGTTAA GTCTTCATCA CACTTTGTGT GACTTAATCA 960 GATTGTGAAT AGGAATTTTA ATTTTGAGTG TGAGGGAAGG ACAGTGGAGG GAGAGCACTA 1020 ATGGGTAGAA ACTCTCCTGT GTAACAGGGG CTATGGGAGA CAAGGGTATC ATTGCATGCT 1080 CTTGTAACTT TTGTTTTGAA TTCATTGAAT TTTTTAAATG AAGAAGATAT TAGTGAGAGT 1140 CTAGTTTAAT TTATTTATTT TATAGGTTAA AAAACGATCC AGAGAGATTT ACTTGTTCAG 1200 GTCTTACAGC TTGTTAGTGA TTGAAAAGGG CCAGTTCAAT CCATTGTCTT TTTAATGCCA 1260 TATTATTTTT GTATTACAGT GGCTTCCTAG CCATTCCTTG ACTTGAAGTG AGAAGAAAAG 1320 GATCAAAGAG AAAAAGAGAC AAAAAGTAAT ATGTATATGT GCCCTTCCAC CTTCTCATTC 1380 TTTTCTTCCT TTATTGTCAG CATATTATAA TATTCTGGTT TTCCATATCT GAAGAACAGA 1440 TCCTGCTTGT ACGGCTAAGG AGCTGTTTTA TTGCAAGTAT TAGAAAACAA AAATATTAGA 1500 GCTTTATTGA GGAGGAAAGT AATAATATAT TTTAAAGGTT TTCTATGCTA TTTTATTTGT 1560 GTTCATCAAA AACACAAGAT CACTTTTTGT GTAGAAAATC TGAATGGGAA GCAAAATCTG 1620 ACTGGAGAAT CCAGTGGTCC AGAGTTACTT TAAGAAGTGA ATATGTTTAA ATAGCAGGGC 1680 CCAATGACAT GCATCCTAGG GCACTTAAAG ATGTGGCAGA TACCATTGCA GAGGCACTAG 1740 CAAATTACCA TGCACAGGAT GTGAAAAGGG CAGAGTAATG GTAGGGCTTC TAAGCCACCA 1800 CTTTTGTTAA TCTAGTGCTC TTTACCACCT CCCCCAAAGC TATAGAAACA AAGAAGCTAT 1860 ACAAAACTCA TATTATCTGC ATTGCACTGG GCTTTGAAGA CACCACTTAT CCAGCCATAC 1920 CCCATTTTCT CAACTTACGC ATCCTAAATG TAAATCCAAT GTGGGTTTTA AGAGCTTGTA 1980 TAATGTCTAT GGAAAATAGA GAGTAGAAAT AGAGCTTCTA TTCACAAGTG TTTCTTGAAT 2040 CCCATTTTTT AGAGTACATT TAGCATACTG 2070
|